Basit öğe kaydını göster

dc.contributor.authorCOUTURIER, A
dc.contributor.authorCHAIKITMONGKOL, V
dc.contributor.authorAMPHORNPHRUET, A
dc.contributor.authorHINDI, I
dc.contributor.authorAGRAWAL, K
dc.contributor.authorCHHABLANI, J
dc.contributor.authorLOEWENSTEIN, A
dc.contributor.authorIGLICKI, M
dc.contributor.authorREHAK, M
dc.contributor.authorInternational, Retina
dc.contributor.authorBUSCH, C
dc.contributor.authorZUR, D
dc.contributor.authorFRASER-BELL, S
dc.contributor.authorLAÍNS, I
dc.contributor.authorSANTOS, AR
dc.contributor.authorLUPIDI, M
dc.contributor.authorCAGINI, C
dc.contributor.authorCebeci, Zafer
dc.contributor.authorRICCI, GD
dc.contributor.authorGIANCIPOLI, E
dc.contributor.authorMANÉ-TAUTY, V
dc.contributor.authorRODRÍGUEZ-VALDÉS, PJ
dc.contributor.authorGABRIELLE, PH
dc.date.accessioned2021-03-03T08:23:12Z
dc.date.available2021-03-03T08:23:12Z
dc.identifier.citationBUSCH C., ZUR D., FRASER-BELL S., LAÍNS I., SANTOS A., LUPIDI M., CAGINI C., GABRIELLE P., COUTURIER A., MANÉ-TAUTY V., et al., "Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.", Acta diabetologica, cilt.55, ss.789-796, 2018
dc.identifier.issn0940-5429
dc.identifier.othervv_1032021
dc.identifier.otherav_173de557-be35-434b-8b1c-51fa9e7c6641
dc.identifier.urihttp://hdl.handle.net/20.500.12627/20977
dc.identifier.urihttps://doi.org/10.1007/s00592-018-1151-x
dc.language.isoeng
dc.titleShall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
dc.typeMakale
dc.relation.journalActa diabetologica
dc.contributor.department, ,
dc.identifier.volume55
dc.identifier.startpage789
dc.identifier.endpage796
dc.contributor.firstauthorID165615


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster